The impact of government reimbursement negotiation on targeted anticancer medicines use and cost in China: A cohort study based on national health insurance data

BACKGROUND: High prices of targeted anticancer medicines (TAMs) result in financial toxicity for patients and the health insurance system. How national price negotiation and reimbursement policy affect the accessibility of TAMs for cancer patients remains unknown. METHODS: In this population-based c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yu, Zhang, Yichen, Wagner, Anita K, Li, Huangqianyu, Shi, Luwen, Guan, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Global Health 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420358/
https://www.ncbi.nlm.nih.gov/pubmed/37566690
http://dx.doi.org/10.7189/jogh.13.04083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420358/
https://www.ncbi.nlm.nih.gov/pubmed/37566690
http://dx.doi.org/10.7189/jogh.13.04083

Ejemplares similares